Non-prescription Inflame Away™-Celadrin® is available in two forms: a softgel and a topical cream application.
A new clinical study - the fourth clinical study performed on the efficacy of Celadrin® during the past six years – demonstrated that Celadrin® can significantly improve knee function and help relieve the painful symptoms of osteoarthritis.
The study reported that after eight weeks of taking Inflame Away™ Celadrin® capsules, average walking ability increased 45 percent, and participants claimed a 35 percent decrease in knee discomfort.
These improvements were statistically significantly better than the results seen in the placebo group, and no negative side effects were found throughout the entire study.
These findings were recently released by Imagenetix, Inc. (OTC: IAGX) - an innovator in scientifically tested, natural-based bioceutical products and maker of Inflame Away™-Celadrin® and presented at the 4th annual "Natural Supplements: An Evidence-Based Update" Medical Conference.
The said study was led by Jay Udani, M.D., a Medical Director of Medicus Research, Medical Director of the Integrative Medicine Program at Northridge Hospital and Assistant Clinical Professor at the UCLA/Geffen School of Medicine and was awarded first place in the "Original Clinical Research Category" competition.
Find more details from the press release.
Comment Preview